Neuroscience. A glutamate pathway to faster-acting a... [Science. 2010] - PubMed

Save items

loading

Related citations in PubMed

N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants. [Arch Gen Psychiatry. 2010]
N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
Krystal JH. Arch Gen Psychiatry. 2010 Nov; 67(11):1110-1.
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. [Science. 2010]
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS. Science. 2010 Aug 20; 329(5994):959-64.
Ketamine and the potential role for rapid-acting antidepressant medications. [Swiss Med Wkly. 2007]
Ketamine and the potential role for rapid-acting antidepressant medications.
Krystal JH. Swiss Med Wkly. 2007 Apr 21; 137(15-16):215-6.
Review Glutamate modulators as novel interventions for mood disorders. [Rev Bras Psiquiatr. 2005]
Review Glutamate modulators as novel interventions for mood disorders.
Mathew SJ, Keegan K, Smith L. Rev Bras Psiquiatr. 2005 Sep; 27(3):243-8. Epub 2005 Oct 4.
Review The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. [Curr Psychiatry Rep. 2007]
Review The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
Maeng S, Zarate CA Jr. Curr Psychiatry Rep. 2007 Dec; 9(6):467-74.

See reviews... See all...

Cited by 2 PubMed Central articles

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease. [Curr Neuropharmacol. 2012]
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.
Huang YJ, Lin CH, Lane HY, Tsai GE. Curr Neuropharmacol. 2012 Sep; 10(3):272-85.
Review Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. [Drugs. 2012]
Review Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.
Mathews DC, Henter ID, Zarate CA. Drugs. 2012 Jul 9; 72(10):1313-33.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Neuroscience. A glutamate pathway to faster-acting antidepressants?
Neuroscience. A glutamate pathway to faster-acting antidepressants?
Science. 2010 Aug 20 ;329(5994):913-4. doi: 10.1126/science.1194313.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Neuroscience. A glutamate pathway to faster-acting antidepressants?

Source

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information